Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA; Department of Psychiatry, Harvard Medical School, Boston, MA, USA.
Department of Psychiatry, University of Illinois at Chicago, Chicago, IL, USA.
J Affect Disord. 2018 Mar 15;229:342-350. doi: 10.1016/j.jad.2017.12.041. Epub 2017 Dec 27.
This pilot randomized controlled trial compared Cognitive Behavior Therapy (CBT) and Supportive Psychotherapy (SP) for the treatment of depression in bipolar I disorder. We also examined whether exploratory verbal memory, executive functioning, and neural correlates of verbal memory during functional magnetic resonance imaging (fMRI) predicted change in depression severity.
Thirty-two adults (ages 18-65) with DSM-IV bipolar I disorder meeting current criteria for a major depressive episode were randomized to 18 weeks of CBT or SP. Symptom severity was assessed before, at the mid-point, and after the 18-week intervention. All participants completed a brief pre-treatment neuropsychological testing battery (including the California Verbal Learning Test-2nd Edition, Delis Kaplan Executive Functioning System [DKEFS] Trail-making Test, and DKEFS Sorting Test), and a sub-set of 17 participants provided usable fMRI data while completing a verbal learning paradigm that consisted of encoding word lists.
CBT and SP yielded comparable improvement in depressive symptoms from pre- to post-treatment. Better retention of learned information (CVLT-II long delay free recall vs. Trial 5) and recognition (CVLT-II hits) were associated with greater improvement in depression in both treatments. Increased activation in the left dorsolateral prefrontal cortex and right hippocampus during encoding was also related to depressive symptom improvement.
Sample size precluded tests of clinical factors that may interact with cognitive/neural function to predict treatment outcome.
Neuropsychological assessment and fMRI offer additive information regarding who is most likely to benefit from psychotherapy for bipolar depression.
本先导随机对照试验比较了认知行为疗法(CBT)和支持性心理治疗(SP)治疗双相 I 型障碍抑郁的效果。我们还研究了探索性言语记忆、执行功能以及功能磁共振成像(fMRI)期间言语记忆的神经相关性是否可以预测抑郁严重程度的变化。
32 名符合当前重性抑郁发作标准的 DSM-IV 双相 I 型障碍成年患者(年龄 18-65 岁)被随机分配到 18 周的 CBT 或 SP 治疗组。在治疗前、治疗中期和 18 周治疗后评估症状严重程度。所有参与者均完成简短的治疗前神经心理测试组合(包括加利福尼亚言语学习测验-第 2 版、德里斯科尔认知灵活性测验[DKEFS]连线测验和 DKEFS 分类测验),17 名参与者中有一部分提供了可用的 fMRI 数据,同时完成了一个包含单词列表编码的言语学习范式。
CBT 和 SP 均能改善治疗前后的抑郁症状。更好地保留所学信息(CVLT-II 长延迟自由回忆与第 5 次试验相比,CVLT-II 正确数)和识别(CVLT-II 击中数)与两种治疗方法中抑郁改善相关。编码期间左背外侧前额叶皮层和右海马体的激活增加也与抑郁症状改善相关。
样本量限制了可能与认知/神经功能相互作用以预测治疗结果的临床因素的测试。
神经心理学评估和 fMRI 提供了关于谁最有可能从双相抑郁的心理治疗中获益的附加信息。